Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AD036 for Mild Sleep Disordered Breathing
NCT04611750Phase 2Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Dec 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised trial in sleep disordered breathing (SDB) comparing Active Medication (AD036) with Placebo Medication (2 arms). Primary endpoint: Snoring Relationship Questionnaire at 14 days. Started Dec 2020; status: completed.
02
Drugs
atomoxetine + oxybutynin
03
Conditions
sleep disordered breathing (SDB)
Beyond the preview
Go deeper on NCT04611750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04611750.